Multi-agent chemotherapy for mast cell tumours in the dog

Veterinary Quarterly

Volumn 20, Issue 1, 1998, Pages 28-31

  Gerritsen, R J ^a   Teske, E ^a   Rutteman, G R ^a   Kraus, J S ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; HYDROXYUREA; PREDNISOLONE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOG; DRUG EFFICACY; FEMALE; HISTAMINE RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MASTOCYTOMA; METASTASIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PARANEOPLASTIC SYNDROME; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOG DISEASES; DOGS; DOXORUBICIN; FEMALE; HYDROXYUREA; MALE; MAST-CELL SARCOMA; NEOPLASM METASTASIS; PREDNISOLONE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; VINCRISTINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031886019     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1998.9694832     Document Type: Article

References (15)

1. Bostock DC. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973; 14: 27–40.
2. Dorr RT, Soble MV, and Albert DS. Interaction of cimitidinc but not ranitidine with cyclophosphamide in mice. Cancer Res 1986; 46: 1795–7.
3. Elling H, and Ungemach FR. Sexual hormone receptors in canine mast cell tumour cytosol. J Comp Pathol 1982; 92:629–30.
4. Forni M. Immunochemical characterization of reactive and neoplastic mast cells. Am J Clin Pathol 1983; 80: 660–4.
5. Goldschmidt MH. and Shofcr FS. Mast cell tumours. In: Goldschmidt MH, and Shofcr FS (cds). Skin tumors of the dog and cat. Oxford: Pergamon Press, 1992:231–51.
6. lardy WD, and Old LJ. L-asparaginasc in the treatment of neoplastic diseases of the dog, cat and cow. Recent Results Cancer Res 1970; 33: 131–9.
7. Hess PW. Canine mast cell tumors. Vet Clin North Am 1977; 7: 13344.
8. Larsen AE, and Grier RL. Evaluation of canine mast cell tumors for presence of estrogen receptors. Am J Vet Res 1989; 50: 1779–80.
9. Macy DW. Canine and feline mast cell tumors: Biologic behaviour, diagnosis, and therapy. Sent Vet Med Surg (Small Anim) 1986; 1:7283.
10. Macy DW, and MacEwcn EG. Mast cell tumors. In: Withrow SJ, and MacEwcn (cds). Clinical Veterinary Oncology. Philadelphia: Lippincolt, 1989: 156–66.
11. Madcwcll BR, and Thcilcn GH: Mast cell and melanocytic neoplasms. In: Theilen GH, and Madewcll (eds). Veterinary Cancer Medicine. Philadelphia: Lea & Gcbigcr, 1987:311.
12. McCaw DI, Miller MA. Ogilvie GK, Withrow SJ, Brewer Jr WG, Klein MK, Bell FW, and Anderson K. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Int Med 1994; 8:4068.
13. O’Keefe DA. Canine mast cell tumors. Vet Clin North Am 1990; 20: 1105–15.
14. Owen LN (cd). TNM classification of tumours in domestic animals. Geneva: World Health Organization, 1980.
15. Patnaik AK, Ehler WN, and MacEwcn EG. Canine cutaneous mast cell tumour: Morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469–74.